When Worlds Collide: The Theory of Real-World Evidence Meets Reality
FDA Law Blog
MAY 13, 2024
FDA recognizes the potential of RWE to support regulatory submissions of medical devices and to inform benefit-risk analysis of such products, while assuring patients have timely access to devices. However, in our experience, there is a large gap between FDA’s lauding the value of RWE and practice.
111 
Let's personalize your content